Peds RAP - Nirsevimab: The Latest Tool to Prevent RSV

Update: 2024-12-19

Description

Nirsevimab - the new RSV monoclonal antibody has been FDA approved for use in infants. Parul and Sol review what it is, how effective it is in preventing severe RSV bronchiolitis, and who should receive it.

Explore Our Podcasts: hippoed.com/podcasts

Comments

In Channel

Shorter is Better (Usually)

2025-09-0312:45

Misinformation is Winning. How Can We Take Back the Narrative?

2025-08-0624:54

Legal Lessons: Vital Signs are Vital

2025-07-0223:41

IU-Doing This Right? Pain and Anxiety Management for IUD Placement

2025-06-0423:25

How Much Do You Really Know About Diverticulitis?

2025-05-0728:51

Measles Alert: Presentation, Management, and More

2025-04-0219:36

Practical MHT Prescribing - You Can Do It!

2025-03-0521:32

OUD Decoded - What is Xylazine (aka "tranq")?

2024-12-2029:35

OUD Decoded - Understanding the Opioid Epidemic

2024-12-2028:52

OUD Decoded - The Rise of Fentanyl: Eli's Story

2024-12-2031:44

ERcast - Lit Matters #1: Artificial Intelligence and Human Values

2024-12-2017:21

ERcast - Intro: Making Sense of the Nonsense

2024-12-2017:25

ERcast - Is Medicine a Vocation or a Profession?

2024-12-2018:15

UC RAP - Legal Lessons: Testicular Torsion

2024-12-2021:59

UC RAP - Eustachian Tube Dysfunction

2024-12-2016:01

UC RAP - Ketorolac Comparisons: What's the Right Dose?

2024-12-2014:16

Peds RAP - Neuroendocrine Causes of Obesity

2024-12-1922:19

Peds RAP - Down Syndrome Part 1

2024-12-1924:58

Peds RAP - Nirsevimab: The Latest Tool to Prevent RSV

2024-12-1912:58

Primary Care RAP - Lipidology 201: Advanced Testing

2024-12-1917:45

00:00

Peds RAP - Nirsevimab: The Latest Tool to Prevent RSV

#box-pro-ellipsis-175709626787053{-webkit-line-clamp:2;}Peds RAP - Nirsevimab: The Latest Tool to Prevent RSV

Peds RAP - Nirsevimab: The Latest Tool to Prevent RSV

Peds RAP - Nirsevimab: The Latest Tool to Prevent RSV